Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
Pre-publication versions of this article are available by contacting email@example.com.
|12 Dec 2008||Submitted||Original manuscript|
|26 Dec 2008||Reviewed||Reviewer Report - Renato Caviglia|
|19 Jan 2009||Reviewed||Reviewer Report - Gert VAN ASSCHE|
|5 Feb 2009||Reviewed||Reviewer Report - Johanna Escher|
|25 Mar 2009||Author responded||Author comments - Pal Miheller|
|Resubmission - Version 2|
|25 Mar 2009||Submitted||Manuscript version 2|
|6 May 2009||Reviewed||Reviewer Report - Renato Caviglia|
|4 Jul 2009||Reviewed||Reviewer Report - Johanna Escher|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|7 Sep 2009||Author responded||Author comments - Pal Miheller|
|Resubmission - Version 4|
|7 Sep 2009||Submitted||Manuscript version 4|
|10 Sep 2009||Editorially accepted|
|10 Sep 2009||Article published||10.1186/1471-230X-9-66|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.